Last reviewed · How we verify
NCT03253562
Metformin Versus Vildagliptin for Diabetic Hypertensive Patients
Phase 4 trial testing Metformin Pill in Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients in 120 participants. Completed in 1 August 2017.
1 August 2017
Quick facts
| Lead sponsor | MTI University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 February 2017 |
| Primary completion | 1 August 2017 |
| Estimated completion | 1 August 2017 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Metformin Pill — full drug profile →
- Vildagliptin 50 mg — full drug profile →
Conditions studied
- Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients — all drugs for Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients →
Sponsor
MTI University
Who can join
Adults 40 to 60, female only, with Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a controlled study to measure the efficacy of using metformin or vildagliptin for type 2 diabetic patients who suffers from hypertension to reduce cardiovascular risk resulting from both diabetes and hypertension using different parameters measuring
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03253562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Metformin Pill
Trials testing the same drug.
- NCT06826092 — Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy · Phase 2 · recruiting
- NCT04984070 — Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety · NA · unknown
- NCT04508634 — Treating Obese PCOS Patients With LSG vs. Met · Phase 4 · unknown
Other MTI University trials
Trials by the same sponsor.
- NCT07510399 — Effect of Extracorporeal Radial Shock Wave Ibuprofen Phonophoresis on Subacromial Space in Patients With Impingement Syn · NA · not yet recruiting
- NCT07394595 — Upper Versus Lower Limb Cycling Exercise With Electrical Muscle Stimulation on Perceptual Responses, Energy Feelings · NA · completed
- NCT07196956 — Effect of Electromagnetic Field Therapy on Balance and Gait in Paraparetic Patients · NA · not yet recruiting
- NCT07334847 — Anterior Foot Wedge With Neuromuscular Training for Balance in Parkinson's Disease · NA · not yet recruiting
- NCT07365748 — Evaluation of Bacterial Contamination and Antimicrobial Efficacy on Charcoal-Infused vs, Standard Nylon Toothbrush Brist · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03253562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MTI University
- Last refreshed: 18 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03253562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing